复旦张江截至二零二五年六月三十日止六个月中期报告

中 期 報 告截 至 二 零 二 五 年 六 月 三 十 日 止 六 個 月 ® 11 390,083408,1244% 383,92498.42%6%408,113®®复美達®49%30%20% ®复美達®®®复美達® 39,774100.00%29,400® 10%7% 181,91059%114,493(36) 20,30313%23,374(37) 177,97615%154,593(38)177,97615%155,330(15) 3921,676(39) 8,74659%21,114(41) 15% 16.5%2,000,0008.25%16.5% 5,62270,34492%1%17% 5,71592%70,473 H 1,106,490,8051,222,481,006 20,731,442 (1) 253,145221,7398.72%2,1322,258 (i)10,242138.0526(ii)2,524.3137276.549026,595.9483414.601639.5663% (2) Adgero Biopharmaceuticals Holdings, IncAdgeroAdgero 400,000AdgeroDelMar Phamarceuticals,IncNASDAQDPMIDelmarDelmarAdergoDelmarKintara Therapeutics,IncNASDAQKTRAKintaraKintaraTuHURA Biosciences,Inc.NASDAQHURATuHURATuHURATuHURA360TuHURATuHURA5,747 (3) (4) 123 2.089 2.087 A1.8173 2.289 2.089 A 826 1 2 WHO4.21.5120.7625.755.54%27.7935.516.32%40%-70%III/IV7,4908,180 (HPV)HPV20030HPV-611 16 180.5%5%80%-90%(TCA)(BCA)5(ALA) 75%-80%65%40复美達® 3 4822571.4%1,92945723.7%50%3,000(IQVIA)3,700 (DNR)ADMEPITHP(MIT) 1)® ®®®®(2021)(2017) ®®®® 2)達® 達®LED 1)® ®Doxil(NCCN)(2024)(2024)(2024) (Photodynamic Therapy, PDT)(Photodynamic Diagnosis, PDD) (antibacterial Photodynamic Therapy, aPDT)(Photoimmunotherapy, PIT)PDT (Intraoperative Molecular Image, IMI)IXIMIIMI ® HPVCINIIIIIII(2022) IIIIIII(European Society for Dermatological Research,ESDR)(2019)(2022) AKIIAK(2021)(2021) ALA NMIBC(MIBC)NMIBCTURBTNMIBCTURBTNMIBCTURBTNMIBC FZ-P001I1(FR) 達®65%40505(b)(1)II達® (ADC) (ADC)ADC Trop2Trop2SN38FDA018IIII linker-drugBB05Me-betterADCBB05ADC Her2Her2BB05FDA022III2HER2IIHER2I(European Society for Medical Oncology Asia, ESMO Asia)HER2BB05HER2IHER2 Trop2Trop2BB05FZ-AD004ITROP-2BB05TROP-2TROP-2I (ADC) DLL3DLL3BB05FZ-AD005IDLL3I(AACR)1.5 mg/kg30 mg/kg ADCADC () () ®達®®4%HPV®®達®99.94%®2%達®7%®®16% GMP144Trop2SN38IIIHer2BB05III () ®®35%® 1. 1. 2. 1 3. 4. cGMPFDAEMAcGMP(CAPA) cGMP cGMP 5. 1. (1) ADC (2) ®達®II 1. (3) EPR ® (4) 2. FZ-P001I 123PCT 3. (%)(%) 4. (%) 5. 11,055 1. 2. 3. ®®達® 4. 5. ®®35% 50% (ADC)ADCADC 101010 C1 a)b)c)d)e)f)g)h)i)j)k)l)m)n) C.2.1 C.2.1 C3 3.21 3.10(1)3.10(2)3.21 3.13 899913101,818,230117,815,229 61,425 A A107,400.009,967.6197,432.3919,310.40 1A23AA4 18,000 19,877 19,877A19,737H140 1.HKSCC NOMINEES LIMITEDH70,564,000H2.210,142,560A139,578,560H70,564,0003.A 571XV 2 3336 (a)571XV78(b)352(c)C2 AC3 2025630 2025630 2025630 2025630 20256306 20256306 5,618,37670,613,805(92,942)(129,051) 5,525,43470,484,754 20256306 2025630620246306 15,917,47536,864,504–– 15,917,47536,864,504 20256306 20256306 (50)(f)(3,638,269)(5,522,836) (51)(b)(3,638,269)(5,522,836) (91,929)131,628 (51)(a)50,205,17626,585,009(51)(a)1,056,285,6291,195,895,997 (51)(c)1,106,490,8051,222,481,006 20256306 20256306 2025630620246306 (3,638,269)(5,489,073) (3,638,269)(5,489,073) (3,638,269)(5,489,073) –– 52,905,16825,661,214943,340,3871,067,294,432 20256306 20256306 20256306 20256306 199611115,295,000 200010205,295,00053,000,000 200011853,000,00053,000,0001 20021 20153,000,0000.10530,000,000 20028 13198,000,0000.10H180,000,000H18,000,000H71,000,000710,000,0000.1 20132 4142,000,000H1.7085,200,000852,000,0000.1 20126 2920136242013102171,000,00092,300,000923,000,0000.1 20131216H 20206 12120,000,0000.10A2020619104,300,0001,043,000,0000.1 20226 714,000,000H1,043,000,0001,029,000,000 20235 112021205A7,572,1000.1103,657,210 20256306 20256306 (9))(10))(12)(14)(23))(14))(19)) (25) (1) 200621515 (2) 20256306202563020256306 (3) 111231 (4) (5) 20256306 (6) (7) (8) (a) (b) 20256306 (9) (a) (i) (1)(2)(3) 20256306 (9) (a) (i) (ii) 12 12 20256306 (9) (a) (ii) 12 (iii) (1)(2)(3) (b) 20256306 (9) (c) (10) (a) (b) (c) (d) (e) (11) 20256306 (11) (a) (b) (c) 20256306 (11) (d) (16)) (12) (a) (b) (c)(16)) (d) (13) (16)) 20256306 (14) (a) 47-50 (b) 5-10 (c) 5-10 (d) 3-10 (e) (f) ••••• (g) (16)) 20256306 (15) (16) (17) (a) (b) 20256306 (17) (c) (18) (19) (9)) (a) (b) (c) 20256306 (20) (21) (22) • 20256306 (23) 12 (1)(2) (24) (1)(2)(3) (25) 20256306 (25) (a) (i) (b) (i) (ii) (iii) (1)15%25% 20256306 (a)2023GR202331000166)32025630615%2024630615%) 2024GR202432006284)320256 30 615%2024630615%) 2022GR202231000054)320256 30615%20246 30615%)2025630620246306 2018112,000,0008.25%16.5%2024630620256306 (2) (a)•[2023]43202311202712315% 20256306 (1) 202563020241231 (a)2025630 (b)202563067,654,495202463065,160,881 2025630 (i) (i)20256306 20256306 (2) (c) (i) 20256 3079,923(2024 123196,54916,62620246 30666,283 2025630(20241231 20256 30202412315%5%) 20256306 (3) (a) 202563020241231318,685,494365,148,5099,295,96411,386,790327,981,458376,535,299 (b)2025630 20256306 (3) (c) (i)202563020241231(ii)2025630 120121 20241231 120121 20256306 (b)2025630 20256306 (b) (i)202563020241231 (ii)2025630 2025630 2025630 20256306 (5) (ii)20241231